Innate Pharma SA Class A (EURONEXT:IPH)

European company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - IPH

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - IPH

  • Market Cap€262.220m
  • SymbolEURONEXT:IPH
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINFR0010331421

Company Profile

Innate Pharma SA is a clinical-stage biotechnology company. The company is engaged in discovering and developing first-in-class therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. It specializes in immuno-oncology, a new therapeutic field that is changing cancer treatment by mobilizing the power of the body's immune system to recognize and kill cancer cells. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies.Innate Pharma SA is a clinical-stage biotechnology company. The company is engaged in developing immunotherapy drugs for cancer and inflammatory diseases.

Latest IPH news

Currently there for this company. Visit our news hub for other news .